Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While MOTS-c improves insulin sensitivity, enhances glycolysis, reduces oxidative stress, and shows protective effects in models of metabolic syndrome, aging, and ischemia-reperfusion injury8135146, Sermorelin is used as a diagnostic agent for assessing GH secretory capacity and as a research tool or off-label therapy to increase endogenous GH in GH-deficient or age-related contexts1727.
While MOTS-c works as a 16-amino-acid mitochondrial-derived peptide that translocates to the nucleus under metabolic stress and regulates glucose and lipid metabolism largely via activation of AMPK and modulation of mTOR and folate-cycle–linked pathways854140146, Sermorelin is a synthetic 29-amino-acid peptide identical to the 1–29 N-terminal fragment of human GHRH that stimulates GH synthesis and secretion by binding pituitary GHRH receptors1727120.
MOTS-c
MT-RNR1
Sermorelin
GHRH
MOTS-c and Sermorelin are noticeably different, with limited direct overlap in their usual biological context. Both are often discussed in Metabolic and endocrine and Aging and longevity contexts, while MOTS-c is more of a mitochondrial peptide and Metabolic peptide and Sermorelin is better described as a hormone peptide. They also influence different molecular systems, with MOTS-c tracking more closely to Mitochondrial membrane while Sermorelin centers more on Growth hormone axis. MOTS-c has a more mitochondrial-encoded origin, while Sermorelin is closer to synthetic analog background and their development context also differs, with MOTS-c in Preclinical development while Sermorelin is approved. Sermorelin incorporates amidation features that are not part of MOTS-c, while their sequence patterns also diverge, with MOTS-c showing hydrophobic domain features and Sermorelin showing alpha-helical domain features.
No related articles are linked to these peptides yet.